Analysis Nu-Med Plus Inc. (NUMD)
5/28/2024
Analysis of Nu-Med Plus Inc. (NUMD)
Nu-Med Plus Inc. is showing some interesting price movements and technical indicators based on the recent data. Here is a brief analysis:1. Price Movement:
- The price has been fluctuating between $0.04010 and $0.06198 over the past few days, showing some volatility in the stock.
- The closing price has been relatively stable around $0.048 - $0.050 range.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) values have been around 45-53, indicating a neutral to slightly bearish sentiment in the market.
- MACD Indicator: The MACD line has been fluctuating around 0, showing a lack of strong momentum in either direction.
- Moving Averages: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all showing values around $0.057 - $0.059, suggesting a consolidation phase.
3. Overall, Nu-Med Plus Inc. seems to be in a consolidation phase with no clear trend direction. Traders and investors may want to wait for a clearer signal or confirmation before making any trading decisions.
Please note that this analysis is based on the provided data and should be supplemented with additional research before making any investment decisions.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.5%
- The next quarter growth rate is 4.8%
- The current quarter growth rate is 5.6%
- The next year growth rate is 9.7%
- The next 5 years compound annual growth rate (CAGR) is 11%
- The past 5 years compound annual growth rate (CAGR) is 20.15%
It can be observed that the company is expected to experience a significant increase in growth compared to the past 5 years, with a particularly high growth rate projected for the next 5 years. This indicates a positive outlook for the company's future performance according to analyst estimates.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released After Hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.1. Financials:
- Cash Flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance Sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, total debt to equity MRQ is 140.968.
- Profit Margin: 26.306%.
- Income Statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.44, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, quarterly earnings growth YoY is -2.2%.
- Operating Margin: 30.743%.
- Return on Assets TTM: 22.073999%.
- Return on Equity TTM: 147.25%.
2. Stock Statistics:
- Short Ratio: 1.66.
- Float Shares: 15,308,320,742.
- Shares Short: 94,308,265.
- Average 10-Day Volume: 52,903,608.
- Average 90-Day Volume: 62,823,269.
- Shares Outstanding: 15,334,099,968.
- Percent Held by Insiders: 5.22%.
- Percent Held by Institutions: 57.555%.
- Short Percent of Shares Outstanding: 0.62%.
3. Valuation Metrics:
- PEG Ratio: 26.213001.
- Forward PE: 26.213001.
- Trailing PE: 29.428572.
- Enterprise Value: $2,948,462,018,560.
- Price to Book MRQ: 39.181313.
- Price to Sales TTM: 7.6151557.
- Enterprise to EBITDA: 22.745.
- Enterprise to Revenue: 7.726.
- Market Capitalization: $2,906,118,684,672.
4. Stock Price Summary:
- Beta: 1.264.
- 50-Day Moving Average: $173.6936.
- 200-Day Moving Average: $180.7906.
- 52-Week Low: $164.08.
- 52-Week High: $199.62.
- 52-Week Change: 8.253%.
5. Dividends and Splits:
- Payout Ratio: 14.93%.
- Dividend Date: May 16, 2024.
- Last Split Date: August 31, 2020.
- Ex-Dividend Date: May 10, 2024.
- Last Split Factor: 4-for-1 split.
- Forward Annual Dividend Rate: $1.
- 5-Year Average Dividend Yield: 0.73%.
- Forward Annual Dividend Yield: 0.5266761603816345%.
- Trailing Annual Dividend Rate: $0.97.
- Trailing Annual Dividend Yield: 0.5108758755701854%.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential decrease in profit margins.
3. The company's gross profit has fluctuated but generally increased from $105 billion in 2020 to $169.1 billion in 2023.
4. Operating income has shown an upward trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing over the years, from $57.4 billion in 2020 to $97 billion in 2023.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased from $3.28 in 2020 to $6.16 in 2023.
7. The company has been able to maintain a consistent number of outstanding shares over the years.
8. Overall, the financial performance of the company in terms of revenue and income has been positive and improving.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant variability, with large amounts being spent on common stock repurchase and debt issuance/payments.
6. Investing activities also vary, with significant amounts being spent on the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's financial activities show a mix of stability in operations and variability in financing and investing decisions.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, compared to $1.26 a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 a year ago.
3. For the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, compared to $6.13 a year ago.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, compared to $6.59 a year ago.
Overall, the analysts are forecasting an increase in earnings per share for both the upcoming quarters and the next fiscal years, indicating positive growth expectations for the company.
MACD of NUMD
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
